438
LETTERS
SYNLETT
The reason is not yet clear why the anti selectivity is obtained at -20°C
and elevation of the reaction temperature causes a reversal of the
enantiofacial selection, although some transition state models can be
considered (Scheme 1). In the aldol reaction mediated by the catalyst 2,
the bromofluoroketene silyl acetal 1 preferentially reacts on the si face
of the aldehydes at -78°C and the fluorine-free dimethylketene methyl
5a,b
trimethylsilyl acetal
also shows the same enantiofacial selection,
suggesting that the catalyst 2 plays the role of a Lewis acid and the
reaction with 1 proceeds via the extended open transition states A and B.
The anti- and syn-aldols are given through transition states A and B,
respectively. On the contrary, the reaction with acetal 1 in the presence
of the catalyst 2 at -20°C preferentially proceeds with re facial
8
enantioselection. We propose the cyclic chair transition states C and D
leading to the reversal of the enantioselectivity when transmetallation to
9
19
a boron enolate rapidly occurs. As shown in the Figure, the F NMR
of a 1:1 mixture of acetal 1 and catalyst 2 in C D NO at -78 and -20°C
2
5
2
10
may suggest the formation of the boron enolate. The anti selectivity
may be caused by the predominant formation of the (E)-boron enolate
and/or by its higher reactivity than the (Z)-isomer. From the (E)-boron
enolate, the corresponding anti-aldol 3 should be obtained via the cyclic
transition state C. However, a cyclic chair transition state (E)
coordinated by the Lewis acid 2 is also a probable model leading to the
11-13
anti-product.
enantioselectivities of the syn- and anti-aldols 3a were determined to be
31% ee and 91% ee, respectively, by HPLC analysis using a chiral
column (Chiralcel OD-H, Daicel Chemical Industries, Ltd.). syn-3a: a
26
colorless oil; [α]
-7.7° (c 0.7, CHCl ); IR (neat) 3467, 2960, 1749,
3
D
-1
1
1265, 1171, 1046, 666 cm ; H NMR (200 MHz, CDCl ) δ 0.92 (d, J =
3
6.5 Hz, 3H), 0.97 (d, J = 6.7 Hz, 3H), 1.19-1.30 (m, 1H), 1.36 (t, J = 7.2
Figure
Hz, 3H), 1.58-2.02 (m, 2H), 2.55-2.62 (m, 1H), 4.02-4.20 (m, 1H), 4.29-
19
4.43 (m, 2H); F NMR (188 MHz, CDCl , CFCl ) δ -129.86 (d, J =
3
3
+
+
A representative experimental procedure is given by the Lewis acid 2
catalyzed reaction of isovaleraldehyde with acetal 1 (Table 1, entry 3):
15.2 Hz, 1F); MS (FAB) m/z 273 [M+1 ], 271 [M+1 ]; HRMS (FAB)
+
Calcd for C H BrFO [MH ] 271.0345. Found 271.0356. anti-3a: a
9
17
26
3
A 1 M THF solution of the BH •THF complex (200 µl, 0.2 mmol) was
3
colorless oil; [α]
-26.2° (c 0.9, CHCl ); IR (neat) 3468, 2959, 1751,
D 3
-1
1
added dropwise to a solution of (1S,2S,5R)-2-isopropyl-5-methyl-1-(N-
1300, 1262, 1047, 867 cm ; H NMR (200 MHz, CDCl ) δ 0.99 (d, J =
3
4'-toluenesulfonamido)cyclohexanecarboxylic acid (71 mg, 0.2 mmol)
6.2 Hz, 3H), 1.02 (d, J = 6.4 Hz, 3H), 1.38 (t, J = 7.2 Hz, 3H), 1.48-2.25
(m, 4H), 4.12-4.32 (m, 1H), 4.39 (q, J = 7.2 Hz, 2H); F NMR (188
19
in EtNO (3 ml) at ambient temperature under an argon atmosphere.
2
The solution was allowed to warm to 45°C, stirred for 1 h and then
cooled to -20°C. The bromofluoroketene silyl acetal 1 (E/Z: 62/38, 308
mg, 1.2 mmol) was added. A solution of isovaleraldehyde (107 µl, 1.0
MHz, CDCl , CFCl ) δ -137.67 (d, J = 20.5 Hz, 1F); MS (FAB) m/z 273
3
3
+
+
+
[M+1 ], 271 [M+1 ]; HRMS (FAB) Calcd for C H BrFO [MH ]
9
17
3
271.0345. Found 271.0336.
mmol) in EtNO (2 ml) was then added using a syringe pump over a 3 h
2
period at -20°C; the resulting solution was stirred at the same
temperature for an additional hour, quenched with a saturated aqueous
References and Notes
(1) For reviews see: (a) Welch, J. T. Tetrahedron 1987, 43, 3123.
(b) Bravo, P.; Resnati, G. Tetrahedron: Asymm. 1990, 1, 661.
(c) Resnati, G. Tetrahedron 1993, 49, 9385.
NaHCO solution and extracted with ether. The combined extracts were
3
washed with brine, dried over anhydrous MgSO , and concentrated in
4
vacuo after filtration. The oily residue was dissolved in a mixture of 2 N
HCl (2 ml) and THF (10 ml) and stirred at ambient temperature for 1 h.
The mixture was extracted with ether. The combined extracts were
(2) (a) Biomedical Aspects of Fluorine Chemistry; Filler, R.;
Kobayashi, Y. Eds.; Kodansha Ltd. and Elsevier Biomedical
Press: Tokyo and Amsterdam, 1982. (b) Biomedical Frontiers of
Fluorine Chemistry; Ojima, I.; McCarthy, J. R.; Welch, J. T. Eds.;
American Chemical Society: Washington, D. C., 1996.
washed with a saturated aqueous NaHCO solution and brine, dried
3
with anhydrous MgSO and filtered. After evaporation of the solvent,
4
the residual crude product was purified by column chromatography with
n-hexane-EtOAc as the eluent on silica gel to afford the syn-aldol (25
mg, 9% yield) and the anti-aldol (210 mg, 78% yield). The
(3) Iseki, K.; Kuroki, Y.; Kobayashi, Y. Tetrahedron Lett. 1997, 38,
7209.